Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens

Vaccine

Volumn 29, Issue 43, 2011, Pages 7505-7513

  Lebens, Michael ^a   Karlsson, Stefan L ^a   Källgård, Susanne ^a   Blomquist, Margareta ^a   Ekman, Annelie ^a   Nygren, Erik ^a   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cholera; Hikojima; Immunogenicity; Serotype; Vaccine; Vibrio cholerae

Indexed keywords

BACTERIAL ANTIGEN; CHOLERA VACCINE; CROSS REACTING ANTIBODY; FORMALDEHYDE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SEROTYPE; VACCINE PRODUCTION; VIBRIO CHOLERAE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; IMMUNOGLOBULIN A; METHYLTRANSFERASES; MICE; MICE, INBRED BALB C; PROMOTER REGIONS, GENETIC; SEROTYPING; VACCINATION; VACCINES, SYNTHETIC; VIBRIO CHOLERAE;

EID: 80053444075     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.121     Document Type: Article

References (25)

1. Cholera - fact sheet N107. 2010 [cited; available from:]. http://www.who.int/mediacentre/factsheets/fs107/en/.
2. Cholera vaccines: WHO position paper. Weekly epidemiological record: World Health Organization; 2010:117-28.
3. Girard M.P., Steele D., Chaignat C.L., Kieny M.P. A review of vaccine research and development: human enteric infections. Vaccine 2006, 24(April (15)):2732-2750.
4. Holmgren J., Kaper J.B. Oral cholera vaccines. New generation vaccines 2010, 506-515. Informa Healthcare USA, Inc., New York. M.M. Levine, G. Dougan, M.F. Good, M.A. Liu, G.J. Nabel, J.P. Nataro (Eds.).
5. Cholera 2009. Weekly epidemiological record: World Health Organization; 2010:293-308.
6. Clemens J.D., Harris J.R., Sack D.A., Chakraborty J., Ahmed F., Stanton B.F., et al. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis 1988, 158(July (1)):60-69.
7. Clemens J.D., Sack D.A., Harris J.R., Chakraborty J., Neogy P.K., Stanton B., et al. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis 1988, 158(August (2)):372-377.
8. Peltola H., Siitonen A., Kyronseppa H., Simula I., Mattila L., Oksanen P., et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 1991, 338(November (8778)):1285-1289.
9. Scerpella E.G., Sanchez J.L., Mathewson I.J., Torres-Cordero J.V., Sadoff J.C., Svennerholm A.M., et al. Safety, immunogenicity, and protective efficacy of the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine against travelers' diarrhea. J Travel Med 1995, 2(March (1)):22-27.
10. Scientific discussion for the approval of Dukoral, European Medicines Agency; 2005 [cited; available from:]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000476/WC500037566.pdf.
11. Karaolis D.K., Lan R., Kaper J.B., Reeves P.R. Comparison of Vibrio cholerae pathogenicity islands in sixth and seventh pandemic strains. Infect Immun 2001, 69(March (3)):1947-1952.
12. Chatterjee S.N., Chaudhuri K. Lipopolysaccharides of Vibrio cholerae: III. Biological functions. Biochim Biophys Acta 2006, 1762(January (1)):1-16.
13. Manning P.A., Stroeher U.H., Morona R. Molecular basis for O-antigen biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching. Vibrio cholerae and cholera: molecular to global perspectives 1994, 77-94. American Society of Microbiologists Press, Washington, D.C. I.K.B.P.A. Wachsmuth, T. Olsvik (Eds.).
14. Gustafsson B., Holme T. Immunological characterization of Vibrio cholerae O:1 lipopolysaccharide, O-side chain, and core with monoclonal antibodies. Infect Immun 1985, 49(August (2)):275-280.
15. Frisk A., Lebens M., Johansson C., Ahmed H., Svensson L., Ahlman K., et al. The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity. Microb Pathog 2001, 30(June (6)):313-324.
16. de Lorenzo V., Timmis K.N. Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol 1994, 235:386-405.
17. Lopez-Vidal Y., Klemm P., Svennerholm A.M. Monoclonal antibodies against different epitopes on colonization factor antigen I of enterotoxin-producing Escherichia coli. J Clin Microbiol 1988, 26(October (10)):1967-1972.
18. Nygren E., Holmgren J., Attridge S.R. Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae. Vaccine 2008, 26(December (52)):6784-6790.
19. Nygren E., Li B.L., Holmgren J., Attridge S.R. Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae. Infect Immun 2009, 77(August (8)):3475-3484.
20. Sanchez J., Holmgren J. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci USA 1989, 86(January (2)):481-485.
21. Losonsky G.A., Yunyongying J., Lim V., Reymann M., Lim Y.L., Wasserman S.S., et al. Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera. Infect Immun 1996, 64(January (1)):10-15.
22. Longini I.M., Yunus M., Zaman K., Siddique A.K., Sack R.B., Nizam A. Epidemic and endemic cholera trends over a 33-year period in Bangladesh. J Infect Dis 2002, 186(July (2)):246-251.
23. Feeley J.C., Gangarosa E.J. Field trials of cholera vaccine. Cholera and related diarrheas 43rd nobel symposium 1980, 204-210. S. Krager, Basel. T. Ouchterlony, J. Holmgen (Eds.).
24. Rhie G.E., Jung H.M., Kim B.S., Mekalanos J.J. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit. Vaccine 2008, 26(October (43)):5443-5448.
25. Harkki A., Hirst T.R., Holmgren J., Palva E.T. Expression of the Escherichia coli lamB gene in Vibrio cholerae. Microb Pathog 1986, 1(June (3)):283-288.